Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the need for regulatory "agility" during the COVID-19 pandemic. EMEA Government & Policy By HIMSS TV | September 15, 2020 | 5:00 PM Topic: Women In Health IT, Population Health, Government & Policy
